Nuo Therapeutics, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
Nuo Therapeutics, Inc. (AURX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of -0.70% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2026-03-30
- Nuo Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2025 was -0.70%.
- Nuo Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2024 was -0.50%.
- Nuo Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2014 was 0.00%, a 100.00% decline from fiscal 2013.
- Nuo Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2013 was 0.90%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | -0.70% 10-K · filed 2026-03-30 | |
| 2024-12-31 | -0.50% 10-K · filed 2026-03-30 | |
| 2014-12-31 | 0.00% 10-K · filed 2015-03-31 | |
| 2013-12-31 | 0.90% 10-K · filed 2015-03-31 | -0.90% 10-K · filed 2014-03-31 |
| 2012-12-31 | -3.70% 10-K · filed 2014-03-31 | |
| 2011-12-31 | -2.00% 10-K · filed 2013-03-18 |